會員登入
註冊
Dive into BRIM Biotechnology, Inc. 's translational medicine strategy that facilitated the enrollment for a Phase III clinical trial of their dry eye disease drug within ONE year! ✨
Discover more in-depth coverage here:
https://lnkd.in/guBmcNhq
Stay tuned to #globalbio for more updates!
#BRIMBiotech #ClinicalTrials #dryeyedisease #translationalmedicine
BRIM Biotech facilitated the enrollment for a Phase III clinical trial of their dry eye disease drug
撰文GlobalBio & Investment
日期2023-12-31
BRIM Biotech facilitated the enrollment for a Phase III clinical trial of their dry eye disease drug
